Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

The Dropout Patient

The Dropout Patient This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor. The reports of White and Hanifin (114:1314-1315, 1978) and of Alomar (114:1316-1319, 1978) in the September issue of the Archives demonstrate a lack of therapeutic effectiveness of levamisole hydrochloride in atopic dermatitis. These studies are difficult to compare because of the age dissimilarities in the two groups studied, and because of the differences in the dose of levamisole utilized. Both of these reports exclude significant consideration of the dropout patient in analyzing their results, a serious omission, in my opinion.In the study by Alomar et al, the dropout rate of 50% is essentially equal in both groups, with eight dropouts from the levamisole group and seven from the placebo group. We are given the reasons for seven of these dropouts, but unfortunately not told from which group(s) these seven patients were. An eighth dropout is assumed by the comment, "There was an untoward reaction in the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

The Dropout Patient

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor. The reports of White and Hanifin (114:1314-1315, 1978) and of Alomar (114:1316-1319, 1978) in the September issue of the Archives demonstrate a lack of therapeutic effectiveness of levamisole hydrochloride in atopic dermatitis. These studies are difficult to compare because of the age dissimilarities in the two groups studied, and...
Loading next page...
 
/lp/american-medical-association/the-dropout-patient-vBuYoCiecT
Publisher
American Medical Association
Copyright
Copyright © 1979 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1979.04010050063035
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract To the Editor. The reports of White and Hanifin (114:1314-1315, 1978) and of Alomar (114:1316-1319, 1978) in the September issue of the Archives demonstrate a lack of therapeutic effectiveness of levamisole hydrochloride in atopic dermatitis. These studies are difficult to compare because of the age dissimilarities in the two groups studied, and because of the differences in the dose of levamisole utilized. Both of these reports exclude significant consideration of the dropout patient in analyzing their results, a serious omission, in my opinion.In the study by Alomar et al, the dropout rate of 50% is essentially equal in both groups, with eight dropouts from the levamisole group and seven from the placebo group. We are given the reasons for seven of these dropouts, but unfortunately not told from which group(s) these seven patients were. An eighth dropout is assumed by the comment, "There was an untoward reaction in the

Journal

Archives of DermatologyAmerican Medical Association

Published: May 1, 1979

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month